Appraisal of clofibrate as a hypolipidemic agent
- 31 May 1968
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 75 (5) , 707-710
- https://doi.org/10.1016/0002-8703(68)90330-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- EFFECT OF CLOFIBRATE ON PLATELET ECONOMY IN MANThe Lancet, 1967
- The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzmalecene—IBiochemical Pharmacology, 1967
- Dynamics of plasma triglyceride turnover in manMetabolism, 1965
- The effects of chlorophenoxyisobutyrate with and without androsterone on the serum lipids, fat tolerance, and uric acidMetabolism, 1965
- Studies with ethyl chlorophenoxyisobutyrate (clofibrate)Metabolism, 1965
- A COMPARISON OF THE EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDSThe Lancet, 1965
- An experimental approach to the problem of disordered lipid metabolismJournal of Atherosclerosis Research, 1963
- EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON ANTICOAGULANT REQUIREMENTSThe Lancet, 1963
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEPublished by Elsevier ,1962
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962